Clinical research advances of isavuconazole in the treatment of invasive fungal diseases

PURPOSE: Invasive fungal diseases (IFD) are a major global public health concern. The incidence of IFD has increased the demand for antifungal agents. Isavuconazole (ISA) is a new triazole antifungal agent that has shown promising efficacy in the prophylaxis and treatment of invasive fungal diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingting, Shen, Yuyan, Feng, Sizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751058/
https://www.ncbi.nlm.nih.gov/pubmed/36530445
http://dx.doi.org/10.3389/fcimb.2022.1049959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751058/
https://www.ncbi.nlm.nih.gov/pubmed/36530445
http://dx.doi.org/10.3389/fcimb.2022.1049959

Ejemplares similares